{"type":"PR","pr":{"number":70,"head":"9c9770c7549ae0e08f93b3bed5d0e3a3b89d2a41"},"user":"silvia.vernotico","status":"draft","branch":"cms/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.66","description":"Sanofi ha ottenuto dalla Commissione europea l’ok per l’autorizzazione all’immissione in commercio di caplacizumab (ALX-0081), prima terapia specifica per il trattamento della aTTP (porpora trombotica trombocitopenica acquisita).","objects":{"entry":{"path":"site/content/hotthisweek/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66.md","sha":"25cb0d8028144c9b2ca8afdd914ed1b0fcf32d66"},"files":[{"path":"/site/static/img/adobe-spark-post.png","sha":"0c7df81ef1f3818869e32dbdf5f389bb7d080516"}]},"timeStamp":"2018-11-14T11:05:39.151Z"}